TScan Therapeutics, Inc.TCRXNASDAQ
Loading
Operating Expenses Over TimeStrong
Percentile Rank100
3Y CAGR+21.7%
5Y CAGR+84.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
+21.7%/yr
Annual compound
5Y CAGR
+84.6%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
21.5x
Strong expansion
Streak
6 yr
Consecutive growthStrong
| Period | Value | YoY Change |
|---|---|---|
| TTM | $144.65M | +5.1% |
| 2024 | $137.64M | +20.2% |
| 2023 | $114.51M | +42.8% |
| 2022 | $80.17M | +36.4% |
| 2021 | $58.78M | +772.0% |
| 2020 | $6.74M | +41.4% |
| 2019 | $4.77M | - |